Inotek Pharmaceuticals Corp Stock price Nasdaq
Equities
US45780V1026
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- | 0.00% |
Mar. 26 | Rocket Pharmaceuticals Appoints Aaron Ondrey as CFO | MT |
Mar. 26 | Rocket Pharmaceuticals, Inc. Announces Appointment of Aaron Ondrey as Chief Financial Officer | CI |
Sales 2024 * | 23.11M 0 | Sales 2025 * | 192M 0 | Capitalization | 2.44B 0 |
---|---|---|---|---|---|
Net income 2024 * | -262M - | Net income 2025 * | -217M - | EV / Sales 2024 * | 98.1 x |
Net cash position 2024 * | 172M 0 | Net cash position 2025 * | 39.19M 0 | EV / Sales 2025 * | 12.5 x |
P/E ratio 2024 * |
-10.1
x | P/E ratio 2025 * |
-14.3
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.49% |
Latest transcript on Inotek Pharmaceuticals Corp
Managers | Title | Age | Since |
---|---|---|---|
Gaurav D. Shah
CEO | Chief Executive Officer | 49 | 18-01-03 |
Kinnari Patel
PSD | President | 46 | 18-01-03 |
Chief Tech/Sci/R&D Officer | 60 | 15-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 77 | 18-01-03 | |
Carsten Boess
BRD | Director/Board Member | 57 | 15-12-31 |
David Southwell
BRD | Director/Board Member | 63 | 14-07-31 |
1st Jan change | Capi. | |
---|---|---|
+2.73% | 108B | |
+9.59% | 103B | |
+6.58% | 23.48B | |
-12.59% | 21.93B | |
-3.29% | 19.68B | |
-36.53% | 18.37B | |
-13.29% | 16.33B | |
+4.68% | 13.72B | |
+34.25% | 12.15B |
- Stock
- Equities
- Stock Rocket Pharmaceuticals, Inc.
- Stock Inotek Pharmaceuticals Corp - Nasdaq